Zacks Investment Research
29 Jul 2026, 18:40 UTC · 4h ago
Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jul 2026, 18:40 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Utah Medical Products (UTMD) reported a 14.3% year-over-year decline in second-quarter 2026 revenues to $8.5 million. — Significant revenue contraction usually signals weakening demand or loss of market share, negatively impacting valuation.
-0.40UTMD's diluted earnings per share (EPS) decreased 10.1% year-over-year to 84.4 cents. — Lower profitability compared to the previous year indicates a decline in bottom-line performance.
-0.30The revenue decline was primarily driven by the total loss of sales from two major former customers, including PendoTECH and a China-based distributor. — The loss of key accounts creates a structural hole in revenue that requires new customer acquisition to fill.
-0.30Continue reading
6 related stories
Top 2 movers · tap to explore
UTMD maintained a gross margin of 55.8%, only a slight contraction from 56.2% in the prior-year quarter. — Stability in margins despite falling revenue suggests the company has decent pricing power or cost control.
+0.20Which stocks this story touches
The company reported declines in EPS, revenues, and net income, primarily due to the loss of major customers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
1h ago
